Olin Corporation (OLN) Company Overview

What does Olin Corporation do?

Olin Corporation, traded on the New York Stock Exchange under OLN, is an industrial company built around three businesses that rarely appear together in one portfolio: chlor-alkali chemicals, epoxy materials, and Winchester ammunition. The company describes itself as a global manufacturer serving customers in nearly 100 countries, with approximately 7,700 employees and 25 manufacturing sites across eight countries. Its official company overview emphasizes leadership positions in chlorine capacity, membrane caustic soda, chlorinated organics, epoxy materials, and small-caliber ammunition.

Why does this portfolio matter?

Chlor Alkali Products and Vinyls supplies chlorine, caustic soda, bleach, hydrochloric acid, ethylene dichloride and related products used in water treatment, construction, pulp and paper, alumina, detergents and many manufacturing chains. Epoxy sells aromatics, allylics, epoxy resins and formulated solutions used in coatings, composites, electronics and infrastructure. Winchester supplies commercial shooters, hunters, law-enforcement agencies and militaries, while also operating the U.S. Army’s Lake City ammunition plant. The combination gives Olin exposure to industrial production, housing and construction, defense spending, consumer ammunition demand, energy and feedstock prices, and global trade flows.

How does Olin make money, and which segment matters most?

Olin earns product revenue rather than subscriptions or transaction fees. Economics therefore depend on realized selling prices, plant utilization, feedstock and energy costs, product mix, maintenance outages, freight, and the discipline with which management balances volume against value. Chlorine and caustic soda are co-products from the same electrochemical process, so producing one also creates the other. This “electrochemical unit” relationship makes capacity decisions unusually important: chasing chlorine volume can oversupply caustic soda, while reducing production to support one market can constrain the other.

What does the FY2025 revenue mix show?

The 2025 Form 10-K shows that Chlor Alkali is the largest revenue source, but its profit is highly cyclical. Winchester remained profitable in 2025, though earnings fell sharply as mix, metals, propellant and pricing moved against it. Epoxy grew sales but remained loss-making, making its turnaround a critical value-creation test.

What does Olin's latest quarter show?

The quarter ended March 31, 2026 showed a company still under significant cyclical pressure. Sales declined 3.7% year over year to $1.583 billion, adjusted EBITDA fell 53.6% to $86.2 million, and Olin recorded an $83.0 million net loss, equal to $0.73 per diluted share. Management nevertheless highlighted sequential improvement and forecast second-quarter adjusted EBITDA of $160 million to $200 million, supported by seasonal demand and improved pricing in chemicals plus stronger commercial and military demand at Winchester.

The official Q1 2026 earnings release also reported negative operating cash flow of $48.6 million and capital expenditure of $43.7 million, implying free cash flow of approximately negative $92.3 million for the quarter. Seasonal working-capital use can reverse, but the result underscores why cash conversion matters as much as adjusted EBITDA.

Which strategic turning points still shape Olin today?

Olin’s present structure is the result of more than a century of industrial consolidation, portfolio change and manufacturing integration. The useful history is not the chronology itself, but how each decision changed scale, asset position or risk.

1. 1892
   The company began as a blasting-powder supplier in East Alton, establishing the explosives and ammunition lineage that became Winchester.
2. 1931
   Olin acquired Winchester, creating the branded ammunition platform that remains a separate reporting segment.
3. 2015
   The combination with Dow’s chlor-alkali and vinyl assets transformed Olin into a global-scale chlor-alkali producer and materially increased leverage and cyclicality.
4. 2020
   Winchester assumed operation of the Lake City Army Ammunition Plant, expanding military exposure, production scale and government-contract importance.
5. 2023
   The $63.5M White Flyer acquisition added clay targets and broadened Winchester beyond cartridges.
6. 2025
   Olin bought AMMO Inc.’s manufacturing assets for $55.8M, adding brass-shellcase capability and a 185,000-square-foot Wisconsin facility.
7. 2025-2026
   Beyond250 cost actions and the end of Blue Water Alliance shifted the chemicals strategy toward lower structural cost and more selective, value-first participation.

What gives Olin a competitive advantage?

Scale, integration and logistics

The strongest moat is physical rather than digital. Chlor-alkali plants are expensive, energy intensive, regulated and tied to pipelines, terminals, railcars, storage and customer locations. Olin states that it has the world’s largest chlorine capacity, a global top-quartile chlor-alkali cost position, a diversified chlorine outlet network, and broad geographic reach in caustic soda and chlorinated organics. Its Epoxy segment also consumes chlorine and caustic soda transferred internally at cost, creating integration that can reduce exposure to external supply and support plant loading.

Brand, contracts and installed capability

Winchester’s advantage comes from brand recognition, distribution, technical know-how and government production capability. The Lake City contract provides scale but also creates customer concentration and termination risk because U.S. government contracts can generally be terminated for convenience. In Epoxy, product qualification, formulation expertise and customer relationships provide some switching friction, but the segment faces aggressive Asian exports and global overcapacity. Thus Olin’s moat is strongest in chlor-alkali infrastructure and Winchester’s brand/production system, and weakest where globally traded epoxy products behave most like commodities.

How financially strong is Olin through the cycle?

FY2025 sales increased 3.7% to $6.781 billion, yet Olin moved from $105.0 million of net income in FY2024 to a $101.1 million net loss. Operating cash flow was $474.2 million and capital expenditure was $226.3 million, producing approximate free cash flow of $247.9 million before acquisitions, supply-contract payments and financing. This illustrates the difference between accounting earnings and cash generation: depreciation and amortization was $521.6 million, reflecting the heavy asset base.

Leverage is the main balance-sheet constraint

At March 31, 2026, Olin had $192.2 million of cash, $2.996 billion of debt and $2.804 billion of net debt. Trailing-twelve-month adjusted EBITDA was $552.4 million, placing net debt to adjusted EBITDA at 5.1 times, up from 4.1 times at December 31, 2025. Total equity was $1.735 billion. This leverage does not imply immediate distress by itself, but it reduces flexibility during weak chemical cycles and raises the importance of pricing recovery, cost reductions and working-capital normalization.

Who owns Olin stock, and why does governance matter?

Olin has one common share class and a dispersed ownership structure rather than founder control. The 2026 proxy reported 113,857,037 shares outstanding on March 2, 2026. Three holders exceeded 5%: Hotchkis & Wiley Capital Management with 13.4%, BlackRock with 9.2%, and Fuller & Thaler Asset Management with 5.6%. Directors and executive officers as a group beneficially owned 1.6%, including shares obtainable within 60 days.

The 2026 proxy statement nominated eight directors for one-year terms after one director’s retirement. Annual elections and majority voting make the board responsive to institutional investors. The practical governance question is whether incentives encourage management to preserve price and cash flow instead of maximizing chemical volume at poor returns.

Which competitors and market forces pressure Olin?

Chemicals rivalry is cyclical and global

In chlor-alkali, Olin competes with large integrated producers such as Westlake, Occidental’s OxyChem, INOVYN, Formosa Plastics and regional producers. Entry barriers are high because plants require capital, permits, power, salt, transportation and customer infrastructure. However, rivalry among existing producers can still be severe when operating rates rise faster than demand. Buyers with storage, import access or multiple suppliers can exert pressure, while electricity, natural gas, ethylene, benzene, propylene and metal inputs affect producer margins.

Epoxy and ammunition have different competitive rules

Epoxy faces global producers including Westlake, Hexion, Huntsman and Asian suppliers. Olin’s filings specifically identify exports from Asia into Europe and North America as a pressure on pricing. Winchester competes with Federal, Remington, Hornady and other ammunition brands, but its scale, retailer relationships and Lake City role differentiate it. Demand can be volatile because commercial ammunition purchases respond to consumer inventory, hunting participation, political expectations and channel stocking, while military revenue depends on project timing and government budgets.

Which KPIs best explain Olin's performance?

Revenue alone can mislead because a volume increase may destroy value if it requires price concessions or poor mix. The most useful dashboard combines segment earnings, pricing and volume bridges, operating rates, maintenance spending, cash conversion and leverage.

How should students interpret margins?

Segment margin equals segment income divided by segment sales. In FY2025, Chlor Alkali’s segment margin was about 4.9%, Winchester’s was about 3.9%, and Epoxy’s was negative 7.5%. These figures show how far profitability had fallen from stronger-cycle conditions. They also explain why a modest price recovery or cost reduction can create substantial operating leverage: much of the manufacturing cost base is fixed in the short run.

What opportunities could improve Olin's earnings power?

The clearest opportunity is a chemicals-cycle recovery combined with structural cost reduction. Management’s Beyond250 program is intended to lower the cost base, while selective participation and reduced uneconomic trading can improve the quality of revenue. A recovery in caustic soda, EDC and epoxy resin pricing would flow through a large installed asset base. The Q1 2026 improvement in Epoxy suggests that lower operating costs and European growth can narrow losses even before a full pricing recovery.

Capital allocation can magnify a recovery

Olin has historically returned capital through dividends and repurchases, but elevated leverage makes debt reduction more valuable today. The company paid $22.8 million in dividends in Q1 2026 and made no share repurchases, compared with $20.2 million of repurchases in Q1 2025. If EBITDA recovers, retaining incremental free cash flow could reduce interest risk and restore flexibility for buybacks, targeted acquisitions or plant investment.

What risks could weaken Olin's outlook?

The principal risk is prolonged oversupply and weak pricing in chemicals while leverage remains elevated. Olin can cut operating rates, but lower utilization increases unabsorbed fixed costs. Epoxy is especially exposed to Asian exports. Chlor Alkali depends on energy and feedstock economics, customer operating rates, trade flows and the balance between chlorine and caustic soda demand. Winchester faces metals and propellant inflation, channel inventory swings, government-contract risk and sensitivity to consumer demand.

Why environmental and operational risk are structural

Olin handles hazardous materials at large, continuous-process facilities. Environmental laws can require capital spending, higher operating cost and remediation. At December 31, 2025, the company expected to use $89.1 million of its environmental reserve in the next five years, $34.5 million in years six through ten, and $32.7 million beyond ten years. Plant outages, storms, accidents or maintenance overruns can also remove high-contribution volume while fixed costs continue.

What is the key takeaway from Olin analysis?

Why does Olin matter for valuation?

Olin is a useful DCF case because normalized earnings are more important than any single year. FY2025 revenue of $6.781 billion did not translate into profit because segment margins were depressed, while Q1 2026 showed further EBITDA pressure. A credible valuation therefore needs a cycle-aware forecast rather than extrapolating the latest loss or a past peak.

Comparable-company analysis should also separate chemicals from ammunition economics. A single consolidated multiple can hide the fact that Chlor Alkali and Epoxy are cyclical, asset-heavy businesses while Winchester has brand and government-contract characteristics. The company’s financials and filings page is the best starting point for updating these assumptions each quarter.

Olin is important because it combines world-scale chlor-alkali infrastructure, a challenged but strategically integrated epoxy platform, and the Winchester ammunition franchise. Its advantage rests on hard-to-replicate assets, logistics, vertical integration, brand and military production capability. Its weakness is equally clear: those assets are capital intensive, cyclical and costly to run below efficient utilization.